Dominique P. Germain

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

Christine M. Eng, Nathalie Guffon, William R. Wilcox et al. · New England Journal of Medicine · 2001 · 1.5K citations · Full text

Medicine, Clinical Sciences, Pharmacology +14

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Derralynn Hughes, Daniel G. Bichet et al. · New England Journal of Medicine · 2016 · 556 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry

William R. Wilcox, João Paulo Oliveira, Robert J. Hopkin et al. · Molecular Genetics and Metabolism · 2007 · 539 citations

Medicine, Pathology, Systemic Pathology +2

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease

Dominique P. Germain, Stephen Waldek, Maryam Banikazemi et al. · Journal of the American Society of Nephrology · 2007 · 435 citations

Medicine, Clinical Sciences, Pharmacotherapy +9

X‐chromosome inactivation in female patients with Fabry disease

Lucía Echevarría, Karelle Bénistan, Anne Toussaint et al. · Clinical Genetics · 2015 · 417 citations

Life Sciences, Genetics, Molecular Genetics +15